AVAC is excited to launch From the Lab to the Jab, a series of advocates’ guides that highlight key advocacy issues to ensure equitable access to safe, effective and affordable vaccines.
Co-created as part of our USAID-supported Coalition to Accelerate and Support Prevention Research (CASPR), with additional support from the New Venture Fund, From the Lab to the Jab issue briefs provide a roadmap for advocacy to advance the development of essential vaccines for HIV, COVID-19, tuberculosis, and other global public health threats, and approaches to ensure equitable access to these life-saving vaccines. Additional topics cover the research and development (R&D) process, the role of mRNA technology; and the need for local vaccine production.
Issue Briefs
From the Lab to the Jab: Vaccine Research and Development
Providing a roadmap for advocacy to advance the development of essential vaccines for HIV, COVID-19, tuberculosis and other global public health threats.
![Thumbnail Image](https://avac.org/wp-content/uploads/2023/11/LabToJab-LocalVaxProduction-thumbnail-792x1024.png)
A Look at mRNA Technology: What is it and What it Means for Global Health Equity
Looking at what mRNA is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.
![Thumbnail Image](/wp-content/uploads/2023/11/LabToJab-mRNA-thumbnail.png)
From the Lab to the Jab: Local Vaccine Production
This issue looks at the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.
![Thumbnail Image](/wp-content/uploads/2023/11/LabToJab-LocalVaxProduction-thumbnail-792x1024.png)
From the Lab to the Jab: Vaccine Access – What’s Working and What’s Next
Examining the web of issues influencing access to vaccines.
![Thumbnail Image](/wp-content/uploads/2023/11/LabToJab-VaccineAccess-thumbnail.png)